Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 12070

1.

Human stem cells transplanted into the rat stroke brain migrate to spleen via lymphatic and inflammation pathways.

Xu K, Lee JY, Kaneko Y, Tuazon JP, Vale F, van Loveren H, Borlongan CV.

Haematologica. 2018 Dec 4. pii: haematol.2018.206581. doi: 10.3324/haematol.2018.206581. [Epub ahead of print]

2.

Combination peptide immunotherapy suppresses antibody and helper T cell responses to the major human platelet autoantigen GPIIb/IIIa in HLA-transgenic mice.

Hall LS, Lennon CS, Hall AM, Urbaniak SJ, Vickers MA, Barker RN.

Haematologica. 2018 Dec 4. pii: haematol.2017.179424. doi: 10.3324/haematol.2017.179424. [Epub ahead of print]

3.

Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypes.

Smitheman KN, Severson TM, Rajapurkar SR, McCabe MT, Karpinich N, Foley J, Pappalardi MB, Hughes A, Halsey W, Thomas E, Traini C, Federowicz KE, Laraio J, Mobegi F, Ferron-Brady G, Prinjha RK, Carpenter CL, Kruger RG, Wessels L, Mohammad HP.

Haematologica. 2018 Dec 4. pii: haematol.2018.199190. doi: 10.3324/haematol.2018.199190. [Epub ahead of print]

4.

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M.

Haematologica. 2018 Dec 4. pii: haematol.2018.206797. doi: 10.3324/haematol.2018.206797. [Epub ahead of print]

5.

Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment.

Brieghel C, Kinalis S, Yde CW, Schmidt AY, Jønson L, Andersen MA, da Cunha-Bang C, Pedersen LB, Geisler CH, Nielsen FC, Niemann CU.

Haematologica. 2018 Dec 4. pii: haematol.2018.195818. doi: 10.3324/haematol.2018.195818. [Epub ahead of print]

6.

T-cell acute lymphoblastic leukemia express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.

de Bock CE, Down M, Baidya K, Sweron B, Boyd AW, Fiers M, Burns GF, Molloy TJ, Lock RB, Soulier J, Taghon T, Van Vlierberghe P, Cools J, Holst J, Thorne RF.

Haematologica. 2018 Dec 4. pii: haematol.2018.198424. doi: 10.3324/haematol.2018.198424. [Epub ahead of print]

7.

Mutational and transcriptomic profiling of acute leukemia of ambiguous lineage reveals obscure but clinically important lineage bias.

Lao ZT, Ding LW, An O, Hattori N, Sun QY, Tan KT, Mayakonda A, Chuan WG, Madan V, Lin DC, Yang H, Koeffler HP.

Haematologica. 2018 Dec 4. pii: haematol.2018.202911. doi: 10.3324/haematol.2018.202911. [Epub ahead of print]

8.

Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow-up of the Swedish compassionate use cohort.

Winqvist M, Andersson PO, Asklid A, Karlsson K, Karlsson C, Lauri B, Lundin J, Mattsson M, Norin S, Sandstedt A, Rosenquist R, Späth F, Hansson L, Österborg A.

Haematologica. 2018 Dec 4. pii: haematol.2018.198820. doi: 10.3324/haematol.2018.198820. [Epub ahead of print]

9.

Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?

Varthaman A, Lacroix-Desmazes S.

Haematologica. 2018 Dec 4. pii: haematol.2018.206383. doi: 10.3324/haematol.2018.206383. [Epub ahead of print]

10.

Kinase activity is impaired in neutrophils of sepsis patients.

Hoogendijk AJ, van Vught LA, Wiewel MA, Fuhler GM, Belkasim-Bohoudi H, Horn J, Schultz MJ, Scicluna BP, Peppelenbosch MP, van 't Veer C, de Vos AF, van der Poll T.

Haematologica. 2018 Dec 4. pii: haematol.2018.201913. doi: 10.3324/haematol.2018.201913. [Epub ahead of print]

11.

Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation.

Radujkovic A, Dai H, Kordelas L, Beelen D, Rachakonda SP, Müller-Tidow C, Kumar R, Dreger P, Luft T.

Haematologica. 2018 Dec 4. pii: haematol.2018.202267. doi: 10.3324/haematol.2018.202267. [Epub ahead of print]

12.

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.

Majhail NS, Murphy E, Laud P, Preussler JM, Denzen EM, Abetti B, Adams A, Besser R, Burns LJ, Cerny J, Drexler R, Hahn T, Idossa L, Jahagirdar B, Kamani N, Loren A, Mattila D, McGuirk J, Moore H, Reynolds J, Saber W, Salazar L, Schatz B, Stiff P, Wingard JR, Syrjala KL, Baker KS.

Haematologica. 2018 Dec 4. pii: haematol.2018.203919. doi: 10.3324/haematol.2018.203919. [Epub ahead of print]

13.

Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein.

Shinohara H, Minami Y, Naoe T, Akao Y.

Haematologica. 2018 Nov 22. pii: haematol.2018.194431. doi: 10.3324/haematol.2018.194431. [Epub ahead of print]

14.

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in haematological malignancies.

Al-Zebeeby A, Vogler M, Milani M, Richards C, Alotibi A, Greaves G, Dyer MJS, Cohen GM, Varadarajan S.

Haematologica. 2018 Nov 22. pii: haematol.2018.204701. doi: 10.3324/haematol.2018.204701. [Epub ahead of print]

15.

First line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.

Eketorp Sylvan S, Asklid A, Johansson H, Klintman J, Bjellvi J, Tolvgård S, Kimby E, Norin S, Andersson PO, Karlsson C, Karlsson K, Lauri B, Mattsson M, Bergendahl Sandstedt A, Strandberg M, Österborg A, Hansson L.

Haematologica. 2018 Nov 22. pii: haematol.2018.200204. doi: 10.3324/haematol.2018.200204. [Epub ahead of print]

16.

Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia.

Bariana TK, Labarque V, Heremans J, Thys C, De Reys M, Greene D, Jenkins B, Grassi L, Seyres D, Burden F, Whitehorn D, Shamardina O, Papadia S, Gomez K; NIHR BioResource, Van Geet C, Koulman A, Ouwehand WH, Ghevaert C, Frontini M, Turro E, Freson K.

Haematologica. 2018 Nov 22. pii: haematol.2018.204784. doi: 10.3324/haematol.2018.204784. [Epub ahead of print]

17.

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high dose anthracycline: subset analysis from ECOG-ACRIN 1900.

Fernandez HF, Sun Z, Litzow MR, Luger SM, Paietta E, Racevskis J, Levine RL, Patel JP, Abdel-Wahab O, Ketterling RP, Dewald GW, Bennett JM, Rowe JM, Lazarus HM, Tallman MS.

Haematologica. 2018 Nov 22. pii: haematol.2018.197277. doi: 10.3324/haematol.2018.197277. [Epub ahead of print]

18.

The population dynamics of haemoglobins A, A2, F and S in the context of the haemoglobinopathies HbS and α+thalassaemia in Kenyan infants.

Macharia AW, Uyoga S, Ndila C, Nyutu G, Makale J, Tendwa M, Nyatichi E, Ojal J, Atkinson S, Williams TN.

Haematologica. 2018 Nov 22. pii: haematol.2018.199596. doi: 10.3324/haematol.2018.199596. [Epub ahead of print]

19.

The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.

Spinello I, Saulle E, Quaranta MT, Pasquini L, Pelosi E, Castelli G, Ottone T, Voso MT, Testa U, Labbaye C.

Haematologica. 2018 Nov 22. pii: haematol.2018.199661. doi: 10.3324/haematol.2018.199661. [Epub ahead of print]

20.

Trypsin encoding PRSS1-PRSS2 variation influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.

Wolthers BO, Frandsen TL, Patel CJ, Abaji R, Attarbaschi A, Barzilai S, Colombini A, Escherich G, Grosjean M, Krajinovic M, Larsen E, Liang DC, Möricke A, Rasmussen KK, Samarasinghe S, Silverman LB, van der Sluis IM, Stanulla M, Tulstrup M, Yadav R, Yang W, Zapotocka E, Gupta R, Schmiegelow K.

Haematologica. 2018 Nov 22. pii: haematol.2018.199356. doi: 10.3324/haematol.2018.199356. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center